Session

Coeliac disease: From pathogenesis to treatment

SAFETY OF BIFIDOBACTERIUM LONGUM NCC 2705 AND PRODUCTION OF ITS SERPIN IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC GLUTEN SENSITIVITY
SAFETY OF BIFIDOBACTERIUM LONGUM NCC 2705 AND PRODUCTION OF ITS SERPIN IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC GLUTEN SENSITIVITY

Coeliac disease: From pathogenesis to treatment  et al.

IS GLUTEN FREE DIET DEFICIENT IN SELENIUM? PROSPECTIVE INTERVENTIONAL STUDY IN CHILDREN WITH CELIAC DISEASE
IS GLUTEN FREE DIET DEFICIENT IN SELENIUM? PROSPECTIVE INTERVENTIONAL STUDY IN CHILDREN WITH CELIAC DISEASE

Coeliac disease: From pathogenesis to treatment  et al.

THE TRANSCRIPTOME OF GLUTEN-SPECIFIC T CELLS IN BLOOD AFTER GLUTEN CHALLENGE
THE TRANSCRIPTOME OF GLUTEN-SPECIFIC T CELLS IN BLOOD AFTER GLUTEN CHALLENGE

Coeliac disease: From pathogenesis to treatment  et al.

POTENTIAL CELIAC DISEASE PATIENTS LACK ACTIVATING NK RECEPTORS AND EPITHELIAL STRESS MARKERS UP-REGULATION EVEN PRIOR TO DEVELOP VILLOUS DAMAGE
POTENTIAL CELIAC DISEASE PATIENTS LACK ACTIVATING NK RECEPTORS AND EPITHELIAL STRESS MARKERS UP-REGULATION EVEN PRIOR TO DEVELOP VILLOUS DAMAGE

Coeliac disease: From pathogenesis to treatment  et al.

REDEFINING THE DIAGNOSIS OF TYPE 1 REFRACTORY COELIAC DISEASE USING URINE GLUTEN IMMUNOGENIC PEPTIDES
REDEFINING THE DIAGNOSIS OF TYPE 1 REFRACTORY COELIAC DISEASE USING URINE GLUTEN IMMUNOGENIC PEPTIDES

Coeliac disease: From pathogenesis to treatment  et al.

Item 1 - 5 / 5
1